Metaclipse Therapeutics

Atlanta, United States

Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company

Jun 2024

Grant

Biotechnology Medical Therapeutics

Top Investors

National Institutes of Health Southern Research Georgia Research Alliance

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Metaclipse Therapeutics

Who are Metaclipse Therapeutics's investors?

Metaclipse Therapeutics's investors include National Institutes of Health, Southern Research, Georgia Research Alliance.

Where is Metaclipse Therapeutics headquartered?

Metaclipse Therapeutics is headquartered in Atlanta, United States.

What does Metaclipse Therapeutics do?

Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company

What stage is Metaclipse Therapeutics at?

Metaclipse Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 28, 2024.

MLA

"Metaclipse Therapeutics — Funding & Investors." VCBacked, June 28, 2024, https://www.vcbacked.co/company/metaclipse-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Metaclipse Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/metaclipse-therapeutics

Wikipedia (cite web)

{{cite web |title=Metaclipse Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/metaclipse-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 28, 2024.